Alhazami, M. (2015). COST EFFECTIVENESS OF WARFARIN IN ANTICOAGULANT CLINIC AFTER INTRODUCTION OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES. VCU Scholars Compass.
Chicago Style (17th ed.) CitationAlhazami, Mai. COST EFFECTIVENESS OF WARFARIN IN ANTICOAGULANT CLINIC AFTER INTRODUCTION OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES. VCU Scholars Compass, 2015.
MLA (8th ed.) CitationAlhazami, Mai. COST EFFECTIVENESS OF WARFARIN IN ANTICOAGULANT CLINIC AFTER INTRODUCTION OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES. VCU Scholars Compass, 2015.
Warning: These citations may not always be 100% accurate.